Skip to main content
OUR LEADERSHIP

Fit-for-purpose expertise

Our strength lies in the quality of the 200+ researchers, data specialists, and technology experts that make up our team, but we are also fortunate to have a life sciences leadership which represents decades of experience within the pharmaceutical and biotech industry.

Genesis card holder

Our leadership team

David Miller

Chairman & Chief Executive Officer

David Miller, PhD is our Chairman and Chief Executive Officer. Prior to Genesis Research Group, David was Senior Vice President of Global Market Access at Biogen. He previously founded a consultancy delivering business and commercial strategies for biopharmaceutical clients and served as Vice President of Pharmacoeconomics; Managing Director, Asset Executive; and Head of International Operations at Elan. David began his career at GSK, culminating in his role as Vice President of Global Health Outcomes.

Frank A. Corvino

Co-Founder and Vice Chairman

Frank A. Corvino is our Co-Founder and Vice Chairman. A quantitative scientist by training, he has spent the last 15 years advancing the way epidemiology, health outcomes, medical affairs and market access leverage RWE for decision-making and stakeholder communications. He has published frequently in Mathematics, Physics, Statistics and Healthcare, and held academic positions at the City University of New York and Stevens Institute of Technology, where he also received his PhD. He holds an MBA from Columbia Business School.

Lynn Okamoto

Chief Business Officer

Dr. Lynn Okamoto is a seasoned senior executive and thought leader with over 25 years of success in the life sciences, including leadership roles at Symphony Health and GSK. She specializes in health economics, providing valuable expertise for go-to-market strategies and product development. She holds a PharmD from the University of Michigan, and has completed both a Clinical Pharmacy Residency and a Pharmacoeconomics Fellowship.

Jennifer Fillman

Chief Financial Officer

Jennifer Fillman MBA is a highly respected executive with over 27 years of corporate, financial, and business experience, including as a general manager for pharmaceutical business units and as Senior Vice President and CFO of a contract research organization’s largest operating segment. She has significant experience in scaling pharmaceutical services businesses to maximize growth potential.

Carolyn Hillegass

Chief Commercial Officer

A strategic business leader with over 25 years of experience driving growth across innovative and transformative healthcare organizations, Carolyn Hillegass ACC previously owned an executive consulting business supporting commercial growth strategies. She has deep knowledge of health economics, RWE, health policy and market access, having supported the commercialization and launch of many key brands.

Michael Livingstone

Chief People Officer

For the past decade, Michael has been fostering company growth on a number of ongoing client relationships, supporting the organization from both the UK and US. He works on talent acquisition, company culture, and employee life. He also introduces executable strategies that harmonize business practices to best deliver client solutions.

Joseph DiCesare

Senior Advisor

Prior to his current role, Joe DiCesare was VP and Global Head of RWE & Modeling at Allergan, having previously spent 20+ years at Novartis, including roles leading the Novartis Global and US HE&OR departments, and the Global Oncology Strategic Pricing team. Joe received his Pharmacy degree from Rutgers University and a Masters in Public Health from the UMDNJ School of Public Health. He is currently an Adjunct Professor at Rutgers College of Pharmacy.

Kuldeep Singh

Executive Vice President

Dr. Kuldeep Kumar Singh is a physician and healthcare expert with 20+ years of industry experience. He specializes in health technology assessment, market access, and pricing for pharmaceuticals and vaccines. He held senior positions at Novartis and WHO, and has executed diverse projects in market access, pricing, health economics, and HTA for companies across Europe and USA. He has an MPH from University College London / Humboldt-Universität zu Berlin / Karolinska Institutet, and an MBA from London Business School.

Deb Casso

Executive Vice President

Deb Casso provides scientific and operational direction for RWE strategy, generation, synthesis, and scientific communications. She has more than 30 years of experience in the design and conduct of observational research studies, including 15 years of experience partnering with life sciences clients on the design, conduct, and strategic considerations of pharmaco-epidemiology and drug safety studies and the use of RWE for both pre- and post-approval regulatory decision-making. Deb has an MPH in Epidemiology from the University of Washington.

Get in touch with our life sciences leadership team

Get in touch

Genesis Research Hub

Publications

Explore our publications for details of our peer-reviewed research and therapeutic experience.

Insights

Delve deeper into Genesis Research: videos, interviews, papers, webinars, and case studies.

News & Events

Check out our latest news and events. We hope to see you soon at an upcoming show or webinar!

Case studies

How our approach, expertise, and research capabilities have impacted upon our clients' success.

Newsletter

Keep current on the latest research and learn more about our work by signing up to our newsletter.

Headquarters:

HOBOKEN
111 River Street, Suite 1120
Hoboken, New Jersey 07030, US